art

Artmarket.com: Double-digit growth in Q2 2025, Revolutionary Artprice-Perplexity AI rapprochement: The Mixed Subscription for the Second Half of 2025/2026 Will Redefine the Intelligence of the Art Market

PARIS, Aug. 7, 2025 /PRNewswire/ -- The Board of Directors, its founding President, and the employees of Artprice are mobilizing…

10 months ago

Art of Time: A Decade of Horological Excellence

Art of Time celebrates a decade of shaping India's luxury watch landscape with a special collaboration with Roger Dubuis that bridges…

10 months ago

Automobili Lamborghini captivates Sylt: performance meets art

An exclusive showcase of Italian super sports cars, design and lifestyle at the Werkhallen Gallerie Kampen on the famous German…

10 months ago

ART COMES TO LIFE AT RUNWAL RAAYA IN WORLI WITH TAO ART GALLERY COLLAB

MUMBAI, India, July 16, 2025 /PRNewswire/ --  Runwal Realty, one of India's most trusted luxury developers, is proud to announce a…

11 months ago

Art Never Melts: Huion’s Prime Day 2025 Cool Creative Deals

LOS ANGELES, July 8, 2025 /PRNewswire/ -- When the cruel summer heat meets Prime Day, why not stay cool indoors and…

11 months ago

Runwal Raaya Hosts an Immersive Evening with Tao Art Gallery

Runwal Raaya transforms into a canvas for contemporary Indian artBollywood's Neha Dhupia & Angad Bedi grace the immersive showcaseAn evening…

11 months ago

“The Most Important Thing About Art is Freedom,” says AR Rahman at IGF London 2025

Oscar-winning composer on scent cinema, AI, and the reinvention of Indian music culture LONDON, June 22, 2025 /PRNewswire/ --  In…

12 months ago

“AI and the Art Market” by Arte, with Artprice by Artmarket and analysis by Perplexity.AI Labs

PARIS, June 16, 2025 /PRNewswire/ -- This Sunday, June 15th, 2025, the Franco-German TV channel Arte broadcast the documentary "AI…

12 months ago

[Ad hoc announcement pursuant to Art. 53 LR] Roche provides safety update on Elevidys gene therapy for Duchenne muscular dystrophy in non-ambulatory patients

After a thorough clinical review, the benefit-risk for the use of Elevidys in non-ambulatory patients with Duchenne has been re-assessed,…

12 months ago

IPSEN – Buy-back programme – Art 5 of MAR – Week 23 – 2025

Aggregated presentation by day and by market Statement of transactions in own shares from June 2nd to June 6th 2025       Name…

12 months ago